Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Chronic myeloid leukemia	7/76	5.774564025891377e-13	6.294274788221601e-11	270.4975845410628	-521.0367099479624	BRAF;CBL;HRAS;KRAS;PTPN11;RAF1;SOS1
KEGG_2021_Human	ErbB signaling pathway	7/85	1.2999057563438945e-12	7.084486372074225e-11	239.01709401709402	-492.0098031644462	BRAF;CBL;HRAS;KRAS;MAP2K7;RAF1;SOS1
KEGG_2021_Human	Neurotrophin signaling pathway	7/119	1.4588888119928622e-11	5.300629350240732e-10	165.75	-411.94914049648423	BRAF;HRAS;KRAS;MAP2K7;PTPN11;RAF1;SOS1
KEGG_2021_Human	Renal cell carcinoma	6/69	6.362284067331453e-11	1.733722408347821e-09	190.5952380952381	-458.23071562132344	BRAF;HRAS;KRAS;PTPN11;RAF1;SOS1
KEGG_2021_Human	Proteoglycans in cancer	7/205	6.890157034599341e-10	1.502054233542656e-08	92.74410774410775	-284.48266779362524	BRAF;CBL;HRAS;KRAS;PTPN11;RAF1;SOS1
KEGG_2021_Human	Insulin signaling pathway	6/137	4.23641592119837e-09	5.772116692632779e-08	90.88167938931298	-275.117151721274	BRAF;CBL;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Endometrial cancer	5/58	3.924235171479762e-09	5.772116692632779e-08	151.22641509433961	-357.01450658069916	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	6/131	3.22986834076209e-09	5.772116692632779e-08	95.316	-285.46143465447136	BRAF;HRAS;KRAS;PTPN11;RAF1;SOS1
KEGG_2021_Human	Acute myeloid leukemia	5/67	8.23250285323093e-09	8.800525011962898e-08	129.1290322580645	-319.121405242259	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	MAPK signaling pathway	7/294	8.613842285651333e-09	8.800525011962898e-08	63.260162601626014	-208.07497507114164	BRAF;HRAS;KRAS;MAP2K7;NF1;RAF1;SOS1
KEGG_2021_Human	Fc epsilon RI signaling pathway	5/68	8.88126377354054e-09	8.800525011962898e-08	127.06349206349206	-315.4298190501735	HRAS;KRAS;MAP2K7;RAF1;SOS1
KEGG_2021_Human	Non-small cell lung cancer	5/72	1.1895933602685599e-08	9.974282789944078e-08	119.41791044776119	-301.5255310007327	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Hepatitis B	6/162	1.1657637504621833e-08	9.974282789944078e-08	76.07692307692308	-238.99790749378803	BRAF;HRAS;KRAS;MAP2K7;RAF1;SOS1
KEGG_2021_Human	Glioma	5/75	1.4651480307214275e-08	1.140722395347397e-07	114.25714285714285	-291.91790397658275	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Colorectal cancer	5/86	2.9395451563588622e-08	2.1360694802874397e-07	98.60493827160494	-261.58735105388666	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	GnRH signaling pathway	5/93	4.370736564994153e-08	2.9775642849022667e-07	90.68181818181819	-245.48357760337638	HRAS;KRAS;MAP2K7;RAF1;SOS1
KEGG_2021_Human	Prostate cancer	5/97	5.4085780869589264e-08	3.467853008697194e-07	86.69565217391305	-237.1712976551275	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	T cell receptor signaling pathway	5/104	7.689793164389816e-08	4.6565969717693884e-07	80.4949494949495	-223.94034919826578	HRAS;KRAS;MAP2K7;RAF1;SOS1
KEGG_2021_Human	Ras signaling pathway	6/232	1.0038183269047773e-07	5.758747243822144e-07	52.04867256637168	-174.3857646205266	HRAS;KRAS;NF1;PTPN11;RAF1;SOS1
KEGG_2021_Human	Bladder cancer	4/41	1.1734085699248772e-07	6.39507670609058e-07	144.7027027027027	-280.59591734901187	BRAF;HRAS;KRAS;RAF1
KEGG_2021_Human	Relaxin signaling pathway	5/129	2.2716633239535927e-07	1.1791014395759124e-06	64.06451612903226	-186.88656585734114	HRAS;KRAS;MAP2K7;RAF1;SOS1
KEGG_2021_Human	FoxO signaling pathway	5/131	2.453717102706871e-07	1.215705291795677e-06	63.03174603174603	-184.44906174375365	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Phospholipase D signaling pathway	5/148	4.5165846521694494e-07	2.036541433308699e-06	55.41958041958042	-166.03116096912797	HRAS;KRAS;PTPN11;RAF1;SOS1
KEGG_2021_Human	Gastric cancer	5/149	4.670966590157567e-07	2.036541433308699e-06	55.02777777777778	-165.06046920792772	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Breast cancer	5/147	4.366280429620726e-07	2.036541433308699e-06	55.816901408450704	-167.01315353572727	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Long-term depression	4/60	5.586483753570852e-07	2.2552841819971216e-06	95.38095238095238	-208.2793311948127	BRAF;HRAS;KRAS;RAF1
KEGG_2021_Human	mTOR signaling pathway	5/154	5.506914925979601e-07	2.2552841819971216e-06	53.147651006711406	-160.36960249388903	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Hepatitis C	5/157	6.062762738655014e-07	2.36014692326213e-06	52.078947368421055	-157.67845628585505	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Long-term potentiation	4/67	8.744364582866104e-07	3.177119131774684e-06	84.70899470899471	-190.62775527188097	BRAF;HRAS;KRAS;RAF1
KEGG_2021_Human	Hepatocellular carcinoma	5/168	8.493017345096659e-07	3.177119131774684e-06	48.49693251533742	-148.5218030993381	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Prolactin signaling pathway	4/70	1.044163095458912e-06	3.671412174355529e-06	80.82828282828282	-183.98664919066243	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Melanoma	4/72	1.1701896109043542e-06	3.985958362142956e-06	78.43137254901961	-179.82105034024002	BRAF;HRAS;KRAS;RAF1
KEGG_2021_Human	Alcoholism	5/186	1.407749997169483e-06	4.649840899741625e-06	43.574585635359114	-135.57193930898038	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Chemokine signaling pathway	5/192	1.6475564077590864e-06	5.281872013110012e-06	42.144385026737964	-131.72377772149218	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	B cell receptor signaling pathway	4/81	1.8822504670820177e-06	5.86186574034114e-06	69.18614718614718	-163.26311048820392	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Gap junction	4/88	2.627125268929808e-06	7.95435150870414e-06	63.36507936507937	-152.4012036590114	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	4/89	2.7491085630604124e-06	8.098725226313106e-06	62.61176470588235	-150.9687540546772	HRAS;KRAS;PTPN11;RAF1
KEGG_2021_Human	Regulation of actin cytoskeleton	5/218	3.086152382817006e-06	8.852384466501412e-06	36.87793427230047	-117.19031279125306	BRAF;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Choline metabolism in cancer	4/98	4.045325673294005e-06	1.1306166625360167e-05	56.5531914893617	-139.20816886591868	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	C-type lectin receptor signaling pathway	4/104	5.130876847568527e-06	1.3981639409624234e-05	53.12	-132.3420645012429	HRAS;KRAS;PTPN11;RAF1
KEGG_2021_Human	Serotonergic synapse	4/113	7.1460852432057485e-06	1.8998129061205526e-05	48.678899082568805	-123.22339060338247	BRAF;HRAS;KRAS;RAF1
KEGG_2021_Human	Growth hormone synthesis, secretion and action	4/119	8.781438908516766e-06	2.278992478638875e-05	46.10434782608696	-117.80575201518995	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Thyroid cancer	3/37	1.0384632752750053e-05	2.6323836512785017e-05	101.26890756302521	-158.85054794063166	BRAF;HRAS;KRAS
KEGG_2021_Human	Pathways in cancer	6/531	1.3121529753006265e-05	3.2505607797220066e-05	21.55142857142857	-76.68025045813094	BRAF;CBL;HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Estrogen signaling pathway	4/137	1.5363738345825308e-05	3.721438843766575e-05	39.774436090225564	-104.03256013781805	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	JAK-STAT signaling pathway	4/162	2.979383554686203e-05	7.05984364045209e-05	33.37552742616034	-89.36652156273904	HRAS;PTPN11;RAF1;SOS1
KEGG_2021_Human	Alzheimer disease	5/369	4.0340680197942286e-05	9.355604556544062e-05	21.164835164835164	-69.66216524591873	BRAF;HRAS;KRAS;MAP2K7;RAF1
KEGG_2021_Human	VEGF signaling pathway	3/59	4.2829644076396207e-05	9.725898342348305e-05	61.316326530612244	-109.395777314067	HRAS;KRAS;RAF1
KEGG_2021_Human	Axon guidance	4/182	4.708801155471762e-05	0.00010474680121355552	29.55056179775281	-80.18631081942894	HRAS;KRAS;PTPN11;RAF1
KEGG_2021_Human	GnRH secretion	3/64	5.4712305971300705e-05	0.00011927282701743554	56.25526932084309	-102.29382199022506	HRAS;KRAS;RAF1
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	4/193	5.926501543349045e-05	0.000126664444750009	27.79188712522046	-75.84859252655446	HRAS;KRAS;MAP2K7;RAF1
KEGG_2021_Human	Focal adhesion	4/201	6.947038219704022e-05	0.00014562060883610353	26.63620981387479	-72.95515241997339	BRAF;HRAS;RAF1;SOS1
KEGG_2021_Human	Central carbon metabolism in cancer	3/70	7.160249860764975e-05	0.00014725796883460044	51.17910447761194	-94.92366080084827	HRAS;KRAS;RAF1
KEGG_2021_Human	Rap1 signaling pathway	4/210	8.243152623376804e-05	0.00016638956221260584	25.44336569579288	-69.93123366666362	BRAF;HRAS;KRAS;RAF1
KEGG_2021_Human	Human immunodeficiency virus 1 infection	4/212	8.553680416035766e-05	0.00016951839369961792	25.192307692307693	-69.28980198257669	HRAS;KRAS;MAP2K7;RAF1
KEGG_2021_Human	Pancreatic cancer	3/76	9.159620399517935e-05	0.00017828546849061694	46.93737769080235	-88.55605413655218	BRAF;KRAS;RAF1
KEGG_2021_Human	Human cytomegalovirus infection	4/225	0.00010785574304042276	0.00020625045598958038	23.671191553544496	-65.36509727839072	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Pathways of neurodegeneration	5/475	0.00013552707217441697	0.0002519323019545362	16.16595744680851	-52.849354173241736	BRAF;HRAS;KRAS;MAP2K7;RAF1
KEGG_2021_Human	Chemical carcinogenesis	4/239	0.00013636702582860217	0.0002519323019545362	22.22127659574468	-61.560372574383265	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Progesterone-mediated oocyte maturation	3/100	0.00020740615092509237	0.0003767878408472511	35.2179675994109	-69.8003308229761	BRAF;KRAS;RAF1
KEGG_2021_Human	Melanogenesis	3/101	0.00021361559897150326	0.0003817065620966206	34.85422740524781	-69.18688807277512	HRAS;KRAS;RAF1
KEGG_2021_Human	Sphingolipid signaling pathway	3/119	0.0003468783323520502	0.0006098344875221527	29.379310344827587	-59.68521503911596	HRAS;KRAS;RAF1
KEGG_2021_Human	Thyroid hormone signaling pathway	3/121	0.00036434044298052937	0.0006303667981726619	28.87409200968523	-58.78131250266827	HRAS;KRAS;RAF1
KEGG_2021_Human	MicroRNAs in cancer	4/310	0.00037183876854062896	0.0006332879026707586	16.910675381263616	-47.03626387241228	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Human papillomavirus infection	4/331	0.0004777466484480537	0.0008011443797051978	15.781855249745158	-43.81753827074924	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Apelin signaling pathway	3/137	0.0005248515914701949	0.0008538630368694215	25.375266524520256	-52.38188378130509	HRAS;KRAS;RAF1
KEGG_2021_Human	Autophagy	3/137	0.0005248515914701949	0.0008538630368694215	25.375266524520256	-52.38188378130509	HRAS;KRAS;RAF1
KEGG_2021_Human	Apoptosis	3/142	0.0005829830335043062	0.000934487509587785	24.447070914696813	-50.640785217242495	HRAS;KRAS;RAF1
KEGG_2021_Human	Signaling pathways regulating pluripotency of stem cells	3/143	0.0005950854077497673	0.000940062455720647	24.26938775510204	-50.30529409222555	HRAS;KRAS;RAF1
KEGG_2021_Human	PI3K-Akt signaling pathway	4/354	0.0006170414755932672	0.0009608217262809445	14.700952380952382	-40.688114366493096	HRAS;KRAS;RAF1;SOS1
KEGG_2021_Human	Oxytocin signaling pathway	3/154	0.0007390260491982426	0.0011345611177832177	22.47019867549669	-46.86692877135684	HRAS;KRAS;RAF1
KEGG_2021_Human	Cellular senescence	3/156	0.0007673816433603202	0.0011617305434204848	22.170868347338935	-46.2873867313738	HRAS;KRAS;RAF1
KEGG_2021_Human	Lipid and atherosclerosis	3/215	0.0019428303639941794	0.002900938488703638	15.881401617250674	-33.55383703082171	HRAS;KRAS;MAP2K7
KEGG_2021_Human	Thermogenesis	3/232	0.0024164136009215383	0.003559311925681725	14.670617592014972	-30.966105875434415	HRAS;KRAS;SOS1
KEGG_2021_Human	Salmonella infection	3/249	0.0029568377027043165	0.00429727079459694	13.627177700348431	-28.69609856443984	HRAS;MAP2K7;RAF1
KEGG_2021_Human	Mitophagy	2/68	0.0030081604419031007	0.004314335370624184	30.310606060606062	-38.524679686703344	HRAS;KRAS
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	2/100	0.006399778215208473	0.00905942630464576	20.331632653061224	-27.120602948412195	HRAS;KRAS
KEGG_2021_Human	Longevity regulating pathway	2/102	0.006650847322673755	0.009294132797069735	19.92	-26.61700675496218	HRAS;KRAS
KEGG_2021_Human	Parathyroid hormone synthesis, secretion and action	2/106	0.0071664154144845515	0.009887838989605267	19.14423076923077	-25.65956234303792	BRAF;RAF1
KEGG_2021_Human	Cholinergic synapse	2/113	0.008111349626545349	0.011051713866168038	17.92117117117117	-24.127023560492017	HRAS;KRAS
KEGG_2021_Human	Vascular smooth muscle contraction	2/133	0.011103972768351109	0.014942383108028034	15.146946564885496	-20.537590301958808	BRAF;RAF1
KEGG_2021_Human	Viral carcinogenesis	2/203	0.024762333575826773	0.032915784875184366	9.784825870646767	-13.073912909097736	HRAS;KRAS
KEGG_2021_Human	cAMP signaling pathway	2/216	0.027803609837697526	0.03651317436516904	9.175233644859814	-12.174459052502558	BRAF;RAF1
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	2/219	0.028526440921903908	0.03701645310104197	9.044930875576037	-11.980722307867735	HRAS;KRAS
KEGG_2021_Human	Endocytosis	2/252	0.036977605273484586	0.047418340880115525	7.818	-10.130623353400585	CBL;HRAS
KEGG_2021_Human	Aldosterone-regulated sodium reabsorption	1/37	0.04489527895199197	0.05690215588101307	24.790123456790123	-13.876145105511855	KRAS
KEGG_2021_Human	Adipocytokine signaling pathway	1/69	0.08225170002715665	0.10305098049379396	13.071895424836601	-7.854937277937848	PTPN11
KEGG_2021_Human	Epithelial cell signaling in Helicobacter pylori infection	1/70	0.08339759626885078	0.10329929537846289	12.880837359098228	-7.74542097629872	PTPN11
KEGG_2021_Human	Bacterial invasion of epithelial cells	1/77	0.09138288226635771	0.11191836142733698	11.68421052631579	-7.04872976578505	CBL
KEGG_2021_Human	Fc gamma R-mediated phagocytosis	1/97	0.11385418156418702	0.1378900643388487	9.226851851851851	-5.553951626329874	RAF1
KEGG_2021_Human	Toll-like receptor signaling pathway	1/104	0.12160016340314761	0.1456529429773966	8.592233009708737	-5.152341092635986	MAP2K7
KEGG_2021_Human	Insulin resistance	1/108	0.12599902727061665	0.14928145622279582	8.2668743509865	-4.943743954376122	PTPN11
KEGG_2021_Human	TNF signaling pathway	1/112	0.13037805537365837	0.15280868855622326	7.964964964964965	-4.748494648054986	MAP2K7
KEGG_2021_Human	Leukocyte transendothelial migration	1/114	0.13256015588280526	0.15371337224708267	7.822025565388397	-4.655477238055189	PTPN11
KEGG_2021_Human	Osteoclast differentiation	1/127	0.1466241030974613	0.16823186565919243	7.00352733686067	-4.115510268264927	MAP2K7
KEGG_2021_Human	Ubiquitin mediated proteolysis	1/140	0.16048249753809815	0.17849583909849692	6.338129496402877	-3.6670604531534	CBL
KEGG_2021_Human	Fluid shear stress and atherosclerosis	1/139	0.15942370386618251	0.17849583909849692	6.384863123993559	-3.698840756963446	MAP2K7
KEGG_2021_Human	Yersinia infection	1/137	0.15730251033809037	0.17849583909849692	6.480392156862745	-3.763669230249352	MAP2K7
KEGG_2021_Human	Cushing syndrome	1/155	0.17622102470306392	0.1940211282084239	5.70995670995671	-3.235678410841787	BRAF
KEGG_2021_Human	cGMP-PKG signaling pathway	1/167	0.1886201000678787	0.2050222457179663	5.289156626506024	-2.942334294710352	RAF1
KEGG_2021_Human	Influenza A	1/172	0.1937366175133076	0.2050222457179663	5.131254061078622	-2.8313674486945275	RAF1
KEGG_2021_Human	Tight junction	1/169	0.19067020323006928	0.2050222457179663	5.224867724867725	-2.8972129419331236	MAP2K7
KEGG_2021_Human	Protein processing in endoplasmic reticulum	1/171	0.19271564324144907	0.2050222457179663	5.162091503267974	-2.8530763101358976	MAP2K7
KEGG_2021_Human	Tuberculosis	1/180	0.20186266926868635	0.21156760529121932	4.896958410924891	-2.6658400097237527	RAF1
KEGG_2021_Human	Neutrophil extracellular trap formation	1/189	0.21091631211370437	0.2189512192418455	4.657210401891253	-2.4954112144854435	RAF1
KEGG_2021_Human	Pathogenic Escherichia coli infection	1/197	0.21888628489075546	0.2250811797461542	4.462585034013605	-2.3563138595912863	PTPN11
KEGG_2021_Human	Epstein-Barr virus infection	1/202	0.22383065271253133	0.22801440323052258	4.3488114980652295	-2.274707784911856	MAP2K7
KEGG_2021_Human	Huntington disease	1/306	0.32049274018188956	0.3234602655539441	2.8280510018214935	-1.1715156192121785	MAP2K7
KEGG_2021_Human	Herpes simplex virus 1 infection	1/498	0.4709527127104428	0.4709527127104428	1.6926000447127207	-0.379898711570649	PTPN11
